This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

Effects of Dry Needling Technique in Hip Abductor Muscles in Subjects With Grade I-III Hip Osteoarthritis

This study is not yet open for participant recruitment.
See Contacts and Locations
Verified June 2017 by Luis Ceballos Laita, Universidad de Zaragoza
Sponsor:
Information provided by (Responsible Party):
Luis Ceballos Laita, Universidad de Zaragoza
ClinicalTrials.gov Identifier:
NCT03202056
First received: June 13, 2017
Last updated: June 25, 2017
Last verified: June 2017
  Purpose

Dry needling is a new treatment technique, addressed to mechanical pain of the neuromusculoskeletal system. Recent investigations has developed new hypothesis about the etiology of the osteoarthritis and could be in relation to musculoskeletal disorders, but there is no published studies evaluating the results of this technique in hip osteoarthritis patients.

The objective of this trial is to evaluate if dry needling is more effective in symptoms, function, range of motion, strength, muscular length, pain threshold and compared to sham dry needling and control.

For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of hip osteoarthritis Grade I-III by Scale of Kellgren and Lawrence.

Patients included are randomized into 3 groups one receive Dry needling, other sham dry needling and the other is a control. Groups receive 3 treatment sessions.

The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in sham dry needling or control group, when the intervention finish the investigators will be given the opportunity to receive the actual technique.


Condition Intervention
Hip Osteoarthritis Other: Dry needling Other: Sham Dry needling

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effects of Dry Needling Technique in Hip Abductor Muscles in Subjects With Grade I-III Hip Osteoarthritis

Resource links provided by NLM:


Further study details as provided by Luis Ceballos Laita, Universidad de Zaragoza:

Primary Outcome Measures:
  • Functional Capacity with functional tests [ Time Frame: Baseline ]
    The investigators measure the functional capacity with functional test: "test Up and Go" (TUG), "20 and 40 meters self-placed" and "30 seconds-chair stand" at baseline

  • Intensity symptoms [ Time Frame: Baseline ]
    The investigators measure the intensity of with a visual analogic scale pre-intervention at baseline

  • Intensity symptoms [ Time Frame: through study completion, an average 21 days ]
    The investigators measure the intensity of with a visual analogic scale at the end of the intervention (3 weeks after baseline the investigators measure the intensity of symptoms through study completion, an average 21 days)

  • Functional Capacity with functional tests [ Time Frame: through study completion, an average 21 days ]
    The investigator measure the functional capacity with functional test: "Test Up and Go" (TUG test), "20 and 40 meters self-placed" and "30 seconds-chair and stand" at the end of the intervention (through study completion, an average 21 days).


Secondary Outcome Measures:
  • Hip Range of motion [ Time Frame: Baseline ]
    The investigators measure the hip range of motion with an inclinometer at baseline

  • Hip Range of motion [ Time Frame: through study completion, an average 21 days ]
    The investigators measure the hip range of motion with an inclinometer at the end of the intervention (through study completion, an average 21 days)

  • Muscular strength [ Time Frame: Baseline ]
    The investigators measure the hip strength with a hand held dynamometer (Lafayette) at baseline

  • Muscular strength [ Time Frame: through study completion, an average 21 days ]
    The investigators measure the hip strength with a hand held dynamometer (Lafayette) at the end of the intervention (through study completion, an average 21 days)

  • Muscular length [ Time Frame: Baseline ]
    The investigators measure the muscular length with Passive Knee Extension test, ELY test, and modified Ober test at baseline

  • Muscular length [ Time Frame: through study completion, an average 21 days ]
    The investigators measure the muscular length with Passive Knee Extension test, ELY test, and modified Ober test at the end of the intervention (through study completion, an average 21 days)

  • Pain threshold [ Time Frame: Baseline ]
    The investigators measure the pain threshold with a digital algometer in myofascial trigger points of the hip muscles, and also other bone areas to discriminate a central sensitization at baseline

  • Pain threshold [ Time Frame: through study completion, an average 21 days ]
    The investigators measure the pain threshold with a digital algometer in myofascial trigger points of the hip muscles, and also other bone areas to discriminate a central sensitization at the end of the intervention (through study completion, an average 21 days)

  • Anxiety and depression with a validated questionnaire (HADS) [ Time Frame: Baseline ]
    The investigators measure the anxiety and depression with HADS questionnaire at baseline

  • Anxiety and depression with a validated questionnaire (HADS) [ Time Frame: through study completion, an average 21 days ]
    The investigators measure the anxiety and depression with HADS questionnaire at the end of the intervention (through study completion, an average 21 days)

  • Functional capacity with a validated questionnaire (WOMAC) [ Time Frame: Baseline ]
    The investigator measure the functional capacity with WOMAC questionnaire at baseline

  • Functional capacity with a validated questionnaire (WOMAC) [ Time Frame: through study completion, an average 21 days ]
    The investigator measure the functional capacity with WOMAC questionnaire at the end of the intervention (through study completion, an average 21 days)


Estimated Enrollment: 60
Anticipated Study Start Date: July 2017
Estimated Study Completion Date: January 2019
Estimated Primary Completion Date: January 2019 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Dry needling
Dry needling technique in each active myofascial trigger point once per week for 3 weeks.
Other: Dry needling
Dry needling is a skilled intervention that uses a thin filiform needle to penetrate the skin and stimulate underlying myofascial trigger points, muscular, and connective tissues for the management of neuromusculoskeletal pain and movement impairments.
Sham Comparator: Sham Dry needling
Sham Dry needling technique in each active myofascial trigger point once per week for 3 weeks.
Other: Sham Dry needling
Sham Dry needling use a non-penetrating acupuncture needle
No Intervention: Control
Control group. No intervention.

  Eligibility

Ages Eligible for Study:   50 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Diagnosed medically with a X-Ray test
  • American College of Rheumatology Criteria

Exclusion Criteria:

  • Secondary osteoarthritis by a traumatism, Paget disease, inflammatory or metabolic disease, congenital diseases etc.
  • Vascular or neurological disease.
  • Musculoskeletal pathologies in lumbar spine, pelvis or lower limbs
  • Grade IV in Kellgren and Laurence Scale
  • Fear of needles
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT03202056

Contacts
Contact: Luis Ceballos Laita +34 677380938 lceballoslaita@gmail.com

Locations
Spain
Luis Ceballos Laita Recruiting
Zaragoza, Spain, 50008
Contact: Luis Ceballos Laita    677380938    lceballoslaita@gmail.com   
Sponsors and Collaborators
Universidad de Zaragoza
  More Information

Responsible Party: Luis Ceballos Laita, Principal Investigator, Universidad de Zaragoza
ClinicalTrials.gov Identifier: NCT03202056     History of Changes
Other Study ID Numbers: C.I.PI17/0182
Study First Received: June 13, 2017
Last Updated: June 25, 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No
Plan Description: The patient data were confidential and were assigned a number to each patient to maintain confidentiality

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Luis Ceballos Laita, Universidad de Zaragoza:
hip osteoarthritis
physiotherapy
manual therapy

Additional relevant MeSH terms:
Osteoarthritis
Osteoarthritis, Hip
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on September 19, 2017